المؤلفون: Huang C; Urological Department, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China., Ai X; Urological Department, The First People's Hospital of Pingjiang, Yueyang, 414500 Hunan, China., Hu L; Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, 570208 Hainan, China., Ren D; Urological Department, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.

المصدر: Journal of immunology research [J Immunol Res] 2022 May 19; Vol. 2022, pp. 6735310. Date of Electronic Publication: 2022 May 19 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101627166 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-7156 (Electronic) Linking ISSN: 23147156 NLM ISO Abbreviation: J Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/diagnosis , Carcinoma, Transitional Cell*/pathology , Carcinoma, Transitional Cell*/surgery , Cystatin B* , Nuclear Proteins* , Urinary Bladder Neoplasms*/diagnosis , Urinary Bladder Neoplasms*/surgery, Biomarkers, Tumor ; Humans ; Neoplasm Recurrence, Local/diagnosis ; Sensitivity and Specificity ; Transcription Factors